
Valrubicin
CAS No. 56124-62-0
Valrubicin( AD-32 )
Catalog No. M21670 CAS No. 56124-62-0
Valrubicin (AD 32) inhibits TPA- and PDBu-induced PKC activation (IC50s: 0.85 and 1.25 μM) and has antitumor and anti-inflammatory activity.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 140 | Get Quote |
![]() ![]() |
10MG | 206 | Get Quote |
![]() ![]() |
25MG | 349 | Get Quote |
![]() ![]() |
50MG | 509 | Get Quote |
![]() ![]() |
100MG | 711 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameValrubicin
-
NoteResearch use only, not for human use.
-
Brief DescriptionValrubicin (AD 32) inhibits TPA- and PDBu-induced PKC activation (IC50s: 0.85 and 1.25 μM) and has antitumor and anti-inflammatory activity.
-
DescriptionValrubicin (AD 32) inhibits TPA- and PDBu-induced PKC activation (IC50s: 0.85 and 1.25 μM) and has antitumor and anti-inflammatory activity.
-
In Vitro——
-
In Vivo——
-
SynonymsAD-32
-
PathwayAngiogenesis
-
TargetPKC
-
RecptorPKC
-
Research AreaCancer
-
IndicationBladder cancer
Chemical Information
-
CAS Number56124-62-0
-
Formula Weight723.64
-
Molecular FormulaC34H32F3NO13
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥125 mg/mL (172.74 mM);Water: Insoluble
-
SMILESCCCCC(OCC([C@]1(O)CC2=C(C(O)=C3C(C4=C(C(C3=C2O)=O)C=CC=C4OC)=O)[C@@H](O[C@]5C[C@](NC(C(F)(F)F)=O)[C@](O)[C@](C)O5)C1)=O)=O
-
Chemical Name2-oxo-2-((2S4S)-2512-trihydroxy-4-(((2S4S5S6S)-5-hydroxy-6-methyl-4-(222-trifluoroacetamido)tetrahydro-2H-pyran-2-yl)oxy)-7-methoxy-611-dioxo-1234611-hexahydrotetracen-2-yl)ethyl pentanoate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Chuang LF et al. Activation of human leukemia protein kinase C by tumor promoters and its inhibition by N-trifluoroacetyladriamycin-14-valerate (AD 32). Biochem Pharmacol. 1992 Feb 18;43(4):865-72.
molnova catalog



related products
-
PKC beta II inhibito...
PKC-IN-1 is a poent PKC beta II inhibitor with Ki of 14.9 nM.
-
Delcasertib
Delcasertib is a potent and selective inhibitor of δ-protein kinase C (δPKC).
-
Psychosine
Psychosine (Galactosylsphingosine) is a PKC inhibitor, a substrate for the enzyme galactosylceramide cerebrosidase (GALC), and a potential biomarker of Krabbe's disease.